Investor relations. The J&J ... Information on tax basis following Kenvue separation. Questions? Please contact us: 1-800-950-5089 · investor-relations@its.jnj.

Abiomed® is committed to leading in technology and innovation, and improving patient outcomes by developing smaller, smarter and more connected technology.

Nov 1, 2022 · ... ABMD), a world leader in breakthrough heart ... Investor Conference Call. Johnson & Johnson ... Reach out to media relations or investor relations.

Abiomed (NASDAQ: ABMD) is a pioneer and global leader in healthcare technology and innovation, with a mission of RECOVERING HEARTS AND SAVING LIVES.

Nov 1, 2022 · “We are committed to investing for growth and look forward to welcoming the talented team and working together to foster our shared patient- ...

Director, Investor Relations. 978-646-1590. ir@abiomed.com. Tom Langford. Director, Communications & Public Relations. 978-882-8408. tlangford@abiomed.com ...

Missing: relations | Show results with:relations

These reports include company annual reports (10K, 10Q), news updates (8K), investor presentations (found in 8Ks), insider trades (form 4), ownership reports ( ...

Nov 1, 2022 · NEW YORK, Nov. ... (ABMD), relating to its proposed acquisition by Johnson & Johnson. Under the terms of the tender offer, ABMD shareholders will ...

Nov 1, 2022 · Please note, you can find today's presentation on the Investor Relations section of the Johnson & Johnson website at investor.jnj.com, following ...